C000017839 Performance — MetLife Russell 2000 Index Portfolio, Class A
Data updated: 2026-08-27
C000017839 returned +22.45% year to date and +40.60% over one year to Jun 2026. Annualised returns are +18.41% over 3 years and +6.97% over 5 years. The fund beat its US Small Blend category average: $100 invested three years ago grew to $166, against $156 for the category, and to $141 over one year, against $133. Volatility over the past three years was 19.93% a year. In the 12 months to Jun 2026 the fund lost a net $126.3M, and assets reached $1.09B.
C000017839 Growth of $100
What $100 invested in MetLife Russell 2000 Index Portfolio grew to, compounded from monthly returns reported on SEC Form N-PORT, against the US Small Blend category average over the same months.
| Period | C000017839 | Category average |
|---|---|---|
| 1 year (Jul 2025 – Jun 2026) | $141 | $133 |
| 3 years (Jul 2023 – Jun 2026) | $166 | $156 |
| 5 years (Jul 2021 – Jun 2026) | $140 | $141 |
| Since data start (Jul 2019 – Jun 2026) | $210 | $209 |
C000017839 Trailing Returns
Total returns to Jun 2026, from SEC N-PORT.
| Period | Total return |
|---|---|
| YTD | +22.45% |
| 1 year | +40.60% |
| 3 years (annualised) | +18.41% |
| 5 years (annualised) | +6.97% |
C000017839 Annual Returns
Calendar-year total returns of MetLife Russell 2000 Index Portfolio, compounded from monthly SEC N-PORT returns. Partial years show the months covered.
| Year | Total return |
|---|---|
| 2026 (Jan–Jun) | +22.45% |
| 2025 | +12.67% |
| 2024 | +11.30% |
| 2023 | +16.79% |
| 2022 | −20.23% |
| 2021 | +14.52% |
| 2020 | +19.63% |
| 2019 (Jul–Dec) | +7.29% |
C000017839 Monthly Returns
Monthly total returns as reported on SEC Form N-PORT.
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | +5.3% | +0.8% | −5.0% | +12.1% | +4.3% | +3.8% | — | — | — | — | — | — |
| 2025 | +2.6% | −5.3% | −6.7% | −2.4% | +5.3% | +5.4% | +1.8% | +7.1% | +3.1% | +1.8% | +1.0% | −0.6% |
| 2024 | −3.9% | +5.6% | +3.6% | −7.0% | +5.0% | −0.9% | +10.1% | −1.5% | +0.7% | −1.5% | +10.9% | −8.3% |
| 2023 | +9.6% | −1.6% | −4.8% | −1.8% | −1.0% | +8.1% | +6.1% | −5.0% | −5.8% | −6.9% | +9.0% | +12.2% |
| 2022 | −9.6% | +1.1% | +1.3% | −9.8% | +0.1% | −8.3% | +10.4% | −2.0% | −9.6% | +11.0% | +2.4% | −6.5% |
| 2021 | +4.6% | +6.2% | +0.9% | +2.2% | +0.1% | +2.0% | −3.5% | +2.2% | −2.9% | +4.3% | −4.1% | +2.3% |
| 2020 | −3.1% | −8.5% | −21.7% | +13.6% | +6.5% | +3.5% | +2.9% | +5.5% | −3.3% | +2.2% | +18.2% | +8.7% |
| 2019 | — | — | — | — | — | — | +0.7% | −4.9% | +1.9% | +2.8% | +4.1% | +2.8% |
C000017839 Risk
Risk measures from monthly returns over Jul 2023 – Jun 2026.
- 3-year volatility (annualised): 19.93%
- 3-year Sharpe ratio: 0.70 (vs 4.5% risk-free rate)
- Best month: +12.15% (Dec 2023)
- Worst month: −8.29% (Dec 2024)
C000017839 Fund Flows
Monthly money in and out of MetLife Russell 2000 Index Portfolio, from SEC Form N-PORT.
- 12-month net flow: −$126.3M
- 12-month gross sales (incl. reinvestments): $126.6M
- Sales ÷ redemptions: 0.50×
| Month | Sales | Redemptions | Net flow |
|---|---|---|---|
| Jun 2026 | $86.5M | $30.8M | $55.7M |
| May 2026 | $2.8M | $22.9M | −$20.1M |
| Apr 2026 | $3.0M | $19.6M | −$16.5M |
| Mar 2026 | $4.0M | $12.9M | −$8.9M |
| Feb 2026 | $11.1M | $20.9M | −$9.8M |
| Jan 2026 | $4.0M | $25.9M | −$22.0M |
| Dec 2025 | $5.2M | $18.6M | −$13.4M |
| Nov 2025 | $1.8M | $11.9M | −$10.1M |
| Oct 2025 | $3.1M | $23.3M | −$20.2M |
| Sep 2025 | $1.5M | $21.8M | −$20.3M |
| Aug 2025 | $1.9M | $21.8M | −$19.9M |
| Jul 2025 | $1.7M | $22.5M | −$20.7M |
C000017839 Assets Under Management
Net assets of MetLife Russell 2000 Index Portfolio by report date, from SEC N-PORT filings.
| Report date | Net assets |
|---|---|
| 2026-06-30 | $1.09B |
| 2026-03-31 | $956.61M |
| 2025-12-31 | $987.14M |
| 2025-09-30 | $1.01B |
| 2025-06-30 | $956.00M |
| 2025-03-31 | $886.19M |
| 2024-12-31 | $988.85M |
| 2024-09-30 | $887.97M |
| 2024-06-30 | $839.42M |
| 2024-03-31 | $888.49M |
| 2023-12-31 | $875.99M |
| 2023-09-30 | $778.09M |
For information only. Not investment advice: figures are as reported in SEC filings and may contain errors or be out of date. Past performance does not guarantee future results.